Events

The conference introduces growth-stage companies (Non-Resource, Technology, Biotech, Special Situations) to active top-level capital finance individuals through a day of scheduled one-on-one meetings.

Biotech Showcase allows companies to build their profile with investors and strategic partners. In addition, presenters conduct one-to-one meetings and participate in informal networking.

Dr. John L. Wallace, Antibe’s Chief Scientific Officer, will deliver a lecture entitled: “Toward Safer and Effective Analgesics: Clinical Trials of an H2S-releasing NSAID for Osteoarthritis” at the flagship annual meeting of the British Pharmacological Society. The programme covers the full range of pharmacological specialties, involving clinical and non-clinical domains in academia and industry.

Dr John L. Wallace, Antibe’s Chief Scientific Officer, will deliver a Keynote Lecture at The Sergio H. Ferreira Conference, named for the late Dr. Sergio Ferreira, whose work led to the development of ACE inhibitors—widely used class of drugs. Dr. Wallace’s lecture is entitled “A Gas From The Past: Safer, More Effective Anti-inflammatory Drugs”.

The conference introduces growth-stage companies (Resource, Technology, Biotech, Special Situations) to active top-level capital finance individuals through a day of scheduled one-on-one meetings.

This is the 69th annual meeting of Korean Pain Society (KPS). The organization has grown into a community of more than 4,800 participating members. KPS plays an important role in Korea in in the domains of education, treatment and research in the field of pain medicine.

Held annually in different cities, BIO-Europe is an international forum to promote business development between pharmaceutical, financial and biotechnology companies. The event is Europe’s largest partnering conference for the global biotech industry.

BioJapan has been fostering interaction between Japanese and companies/organizations to stimulate new business opportunities for almost two decades.

This annual Congress is the major event in the calendar of world rheumatology. It brings together physicians, scientists, patients of all ages and their families, health professionals and professionals representing the pharmaceutical industry, from across Europe and around the world.